Ustekinumab and Vedolizumab Are Not Associated With Subsequent Cancer in IBD Patients with Prior Malignancy is a research paper published in Inflammatory Bowel Diseases (2022). On theSindex it has a DataRank of 0.584. It has been cited 48 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.584
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: K23DK124570
Crohn's & Colitis Foundation
Grant: 702804
National Institutes of Health
Grant: 5K23DK124570-03
The Role of Enteric Infection in Flares of Inflammatory Bowel Disease
Crohn's and Colitis Foundation
Judith & Stewart Colton Center for Autoimmunity
FWCI
7.23
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals